Strategic partnerships Breakthrough T1D actively forms collaborations with technology and pharmaceutical partners (Canon Canada, Supra ITS, Bayer) to modernize IT, strengthen cybersecurity, and support clinical research. This indicates openness to multi-vendor programs, managed services, and joint funding or sponsorship opportunities.

Fundraising and visibility With a revenue range in the high billions and a track record of fundraising events and high-profile galas, there is strong capacity and appetite for donor engagement services, event partnerships, corporate sponsorship programs, and fundraising technology platforms to scale campaigns.

Clinical research focus Active involvement in clinical trials and research congresses (CRC 2026) signals demand for trial management, data infrastructure, regulatory consulting, patient recruitment, and health IT integrations tailored to research ecosystems.

Global expansion Recent leadership changes and planned international events, plus partnerships across regions (North America, Australia, Canada), suggest opportunities in global program deployment, regional chapters support, localization services, and distributed workforce IT solutions.

Technology modernization Current tech stack and recent IT modernization efforts imply a receptiveness to cybersecurity, system integration, cloud/DevOps tooling, and analytics platforms to support scaled operations and donor/volunteer management.